India's top Army hospital has successfully performed the country's first government-based LVAD implantation, akin to a ...

Advances in technology have made it increasingly easier for people to self-monitor their heart health, whether it's via a ...

Boston Scientific Corporation BSX recently presented data supporting the use of the FARAPULSE Pulsed Field Ablation (“PFA”) ...

Boston Scientifics FARAPULSE PFA System is approved for pulmonary vein isolation (PVI) in patients who have paroxysmal AF, a ...

In a heartwarming story from the streets of Mumbai, a 70-year-old watchman called Guptaji has captured the city's heart with his extraordinary dedication to his ...

The East Texas Mega Heart Health Fair will be held from 10 a.m. to 2 p.m. Feb. 21 at Lufkin’s Pitser Garrison Convention Center.

TD Cowen reiterated a Buy rating for Boston Scientific (NYSE:BSX) stock, maintaining a price target of $110.00. The stock, currently trading at $98.78, has shown remarkable momentum, reaching new ...

Boston Scientific (NYSE: BSX) today reported data from separate studies backing its Farapulse and Watchman FLX systems.

Boston Scientific Corp. reported positive data for two key atrial fibrillation therapies at AF Symposium 2025 on January 17. In late-breaking data presentations, the ADVANTAGE AF trial for the ...

Boston Scientific (BSX) announced data supporting the use of the FARAPULSE Pulsed Field Ablation System* and the WATCHMAN ...